Complete Guide to Thyroid Medications

How the Thyroid Works

The thyroid gland in the neck produces two key hormones: thyroxine (T4) and triiodothyronine (T3). These hormones regulate metabolism, heart rate, body temperature, energy levels, and many other functions throughout the body.

Thyroid hormone production is controlled by the pituitary gland via thyroid-stimulating hormone (TSH): when thyroid hormone levels drop, TSH rises to stimulate production; when levels are adequate, TSH falls. TSH testing is the cornerstone of thyroid monitoring.

Hypothyroidism: The thyroid makes too little hormone — causing fatigue, weight gain, cold intolerance, constipation, dry skin, and slowed thinking. The most common cause is Hashimoto's thyroiditis (autoimmune destruction of the thyroid).

Hyperthyroidism: The thyroid makes too much hormone — causing weight loss, rapid heartbeat, heat intolerance, anxiety, sweating, and tremor. Common causes include Graves' disease and toxic nodular goiter.

Hypothyroidism Treatment

Hypothyroidism is treated by replacing the missing hormone with synthetic levothyroxine (L-thyroxine, T4) — available under brand names Synthroid, Levoxyl, Tirosint, and others.

Levothyroxine is structurally identical to the T4 the thyroid produces naturally. The body then converts T4 to the more active T3 in peripheral tissues, as it would under normal circumstances.

Dosing is weight-based as a starting point (typically 1.6 micrograms/kg/day for complete replacement) but must be refined through TSH monitoring. Most patients require lifelong daily therapy — hypothyroidism rarely resolves on its own.

bioavailabilityBioavailability

The fraction of an administered drug dose that reaches systemic circulation in unchanged form. IntravenousIntravenous

A route of drug administration where medication is delivered directly into a vein, providing immediate and complete bioavailability. IV administration allows precise dosing control and is used when ra

drugs have 100% bioavailability by definition, while oral drugs are typically lower due to in

-and-consistency">Levothyroxine: Bioavailability and Consistency

Bioavailability — the fraction of a dose that reaches the bloodstream unchanged — is critical for levothyroxine. Oral bioavailability of levothyroxine averages 70–80%, but this varies significantly depending on:

• Whether the tablet is taken on an empty stomach (bioavailability is highest when taken 30–60 minutes before food)
• Concurrent medications that interfere with absorption (calcium supplements, antacids, iron, cholestyramine, proton pump inhibitors)
• The specific formulation and manufacturer

Levothyroxine has a narrow therapeutic window — small changes in dose or absorption significantly affect TSH levels and symptoms. This is why switching between brands or generics should be done cautiously and followed by TSH rechecking 6–8 weeks later.

Brand consistency matters: The FDA approves levothyroxine generics as bioequivalent, but subtle formulation differences between manufacturers have led many endocrinologists to recommend patients stay on the same brand or generic manufacturer once stable.

Therapeutic Drug MonitoringTherapeutic Drug Monitoring

The measurement of drug concentrations in blood at specific times to optimize individual dosing. TDM is essential for drugs with narrow therapeutic indices, significant pharmacokinetic variability, or

for Thyroid

Therapeutic drug monitoring (TDM) is particularly important for levothyroxine because:

• TSH is the most sensitive indicator of thyroid hormone adequacy — a TSH in the normal range (0.4–4.0 mIU/L) for most adults confirms the dose is appropriate
• TSH changes lag behind dose changes by 4–8 weeks — this is why monitoring is done 6–8 weeks after any dose adjustment
• TSH targets shift with special circumstances: lower (0.1–2.5) during pregnancy, possibly lower for thyroid cancer suppression, possibly higher for the very elderly

Over-replacement (TSH too low) is associated with atrial fibrillation, osteoporosis, and heart problems. Under-replacement (TSH too high) leaves patients with lingering hypothyroid symptoms. Getting the dose right is a balance achieved through serial monitoring.

T3-Containing Therapies

Most patients do well on levothyroxine alone because peripheral T4-to-T3 conversion is sufficient. However, some patients report persistent fatigue and cognitive symptoms despite normal TSH on levothyroxine alone.

Options explored in this group: - Liothyronine (Cytomel): Synthetic T3 — faster onset and shorter half-lifeHalf-Life

The time required for the plasma concentration of a drug to decrease by 50%. Half-life determines how often a medication needs to be dosed — drugs with shorter half-lives require more frequent dosing

than T4. Used in combination with levothyroxine in some patients, though evidence for benefit over T4 alone is mixed. - Desiccated thyroid extract (DTE): Derived from porcine thyroid gland; contains both T4 and T3 in a fixed ratio. Used by some patients who prefer a "natural" formulation. TSH monitoring is more complex due to the T3 content.

These alternatives require specialist guidance.

Hyperthyroidism and Antithyroid Drugs

Antithyroid drugs (methimazole, propylthiouracil/PTU) reduce thyroid hormone synthesis by blocking the enzyme that incorporates iodine into thyroid hormone molecules.

• Methimazole is preferred for most patients: once-daily dosing, more effective, lower risk of serious liver toxicity.
• PTU is preferred in the first trimester of pregnancy (methimazole carries a small risk of fetal developmental abnormalities) and in thyroid storm (it also blocks peripheral T4-to-T3 conversion).

Antithyroid drugs are used to achieve euthyroid state (normal thyroid function) as a bridge to definitive treatment, or as long-term therapy in patients who decline other options. Remission of Graves' disease after 1–2 years of treatment occurs in 30–50% of patients.

Rare but serious risks include agranulocytosis (severe white blood cell drop) — patients should report sore throat or fever promptly.

Radioactive Iodine and Surgery

Definitive treatments for hyperthyroidism:

• Radioactive iodine (RAI, I-131): Taken orally; the thyroid absorbs iodine and the radiation destroys thyroid cells. Most patients develop hypothyroidism afterward and require lifelong levothyroxine. It is safe, effective, and widely used.
• Thyroidectomy (surgery): Surgical removal of part or all of the thyroid. Recommended when a large goiter causes compression symptoms, when cancer is suspected, or when other treatments are not appropriate.

Beta-Blockers in Hyperthyroidism

Beta-blockers (propranolol, atenolol) are used as adjunct therapy to rapidly control the symptomatic effects of excess thyroid hormone — rapid heartbeat, tremor, anxiety, and sweating — while waiting for antithyroid drugs to take effect (which takes weeks).

Propranolol also modestly blocks peripheral T4-to-T3 conversion at higher doses. Beta-blockers do not lower thyroid hormone levels themselves — they manage symptoms while the underlying problem is treated.

Drug and Food Interactions

Levothyroxine absorption is significantly reduced by: - Calcium carbonate: Separate from levothyroxine by at least 4 hours - Iron supplements: Separate by at least 2–4 hours - Antacids containing magnesium or aluminum - Proton pump inhibitors: Reduce stomach acid needed for tablet dissolution - High-fiber foods: Soybean products, walnuts, and large amounts of fiber can reduce absorption - Coffee: Taking levothyroxine with coffee reduces absorption — take with water only

Certain medications (rifampin, carbamazepine, phenytoin) accelerate levothyroxine metabolism, requiring dose increases.

Key Takeaways

• Hypothyroidism is treated with levothyroxine — synthetic T4 taken daily on an empty stomach.
• Bioavailability of levothyroxine is affected by food, calcium, iron, and antacids — consistency in timing and brand matters.
• TSH is the primary monitoring tool — checked 6–8 weeks after any dose change.
• Hyperthyroidism is treated with antithyroid drugs (methimazole or PTU), radioactive iodine, or surgery.
• Beta-blockers control hyperthyroid symptoms quickly while antithyroid drugs take weeks to lower hormone levels.
• Antithyroid drug serious risks (agranulocytosis) require prompt attention to fever or sore throat.